HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutational analysis in longest known survivor of mucopolysaccharidosis type VII.

Abstract
Mucopolysaccharidosis VII (MPS VII) is an autosomal recessive disorder caused by the deficiency of beta-glucuronidase leading to the intralysosomal storage of heparan, dermatan, and chondroitin sulfate. Here, we report the identification of two novel missense mutations K350N and R577L in a 37-year-old patient with beta-glucuronidase deficiency and a relatively mild MPS VII phenotype. Expression of the K350N mutation in baby hamster kidney cells has revealed residual enzymatic activity and normal transport of the enzyme to the lysosome. However, expression of the R577L or the double mutant K350N/R577L results in rapid degradation of the enzyme in early biosynthetic compartments and a total loss of enzymatic activity. We attribute the mild phenotype to the residual catalytic activity provided by the K350N mutant. At the time of her death at the age of 37 years, this patient was the longest known survivor with MPS VII.
AuthorsStephan Storch, Birgit Wittenstein, Rafiqul Islam, Kurt Ullrich, William S Sly, Thomas Braulke
JournalHuman genetics (Hum Genet) Vol. 112 Issue 2 Pg. 190-4 (Feb 2003) ISSN: 0340-6717 [Print] Germany
PMID12522561 (Publication Type: Case Reports, Comparative Study, Journal Article)
Chemical References
  • DNA Primers
  • Methionine
  • Glucuronidase
Topics
  • Animals
  • Blotting, Western
  • Cell Line
  • Cricetinae
  • DNA Mutational Analysis
  • DNA Primers (chemistry)
  • Dogs
  • Enzyme Stability
  • Female
  • Glucuronidase (deficiency, genetics, metabolism)
  • Humans
  • Kidney (cytology, enzymology)
  • Methionine (metabolism)
  • Mice
  • Middle Aged
  • Mucopolysaccharidosis VII (enzymology, genetics)
  • Mutagenesis, Site-Directed
  • Phenotype
  • Point Mutation
  • Polymerase Chain Reaction
  • Precipitin Tests
  • Rats
  • Survivors
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: